Journal
CLINICS IN LIVER DISEASE
Volume 22, Issue 1, Pages 11-+Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.cld.2017.08.003
Keywords
Insulin resistance; Metabolic syndrome; Obesity; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Fibrosis; Steatosis; Cirrhosis
Categories
Funding
- NIH [UDK 505, P50AA024333, U01 AA021893]
Ask authors/readers for more resources
Nonalcoholic fatty liver disease (NAFLD) is a major cause of chronic liver disease worldwide, and its clinical and economic burden will continue to grow with parallel increases in rates of obesity, diabetes, and the metabolic syndrome. Evolving understanding of the natural history of NAFLD suggests that these patients are at risk for disease progression to steatohepatitis, fibrosis, and cirrhosis. Recent studies also suggest that these patients are at elevated risk for cardiovascular-, malignancy-, and liver-related morbidity and mortality, although their risk for progression, decompensation, and hepatocellular carcinoma may be less than that of patients with alternative causes of chronic liver disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available